Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Chromosome 20 trisomy, (also called trisomy 20) is a condition in which a fetus or individual has an extra full or partial copy of chromosome 20 in some or allof of his/her cells. An extra full copy of chromosome 20 in all of a person's cells is rare, and almost all fetuses with this do not survive past the first trimester ofpregnancy. The presence of an extra copyof only part of chromosome 20 is called partial trisomy 20; and an extra copy of chromosome 20 in only some of a person's cells is called mosaic trisomy 20. Mosaic trisomy 20 is the most common type of chromosome 20 trisomy and is one of the more common chromosomal abnormalities found during prenatal diagnostic testing. Studies have shown that the child is normal in the vast majority of prenatally diagnosed individuals. However, features that have been reported include spinal abnormalities (including spinal stenosis, vertebral fusion, and kyphosis), hypotonia (decreased muscle tone), life long constipation, sloped shoulders, and significant learning disabilities despite normal intelligence. Trisomy 20 usually results from an error that occurs when an egg or sperm cell develops (before fertilization); mosaic trisomy 20 usually results from errors in cell division soon after fertilization.
Biomarker and diagnostic research for chromosome 20 trisomy has been reported in the published literature.
No clinical trials have been registered for chromosome 20 trisomy.
13 publications have been identified in PubMed for chromosome 20 trisomy. Research spans Case Report / Case Series (54%), Clinical Trial Publication (15%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 54% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Genetic and Rare Diseases Info Center
Common questions about chromosome 20 trisomy
2 |
15% |
Disease patterns and progression | 2 | 15% |
Testing and diagnosis research | 1 | 8% |
Laboratory research | 1 | 8% |
Chen CP (2026). [PMID: 41813405](https://pubmed.ncbi.nlm.nih.gov/41813405/). *Taiwanese journal of obstetrics & gynecology*. [Case Report / Case Series]
Hu J (2025). [PMID: 41334769](https://pubmed.ncbi.nlm.nih.gov/41334769/). *International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics*. [Clinical Trial Publication]
Chen CP (2025). [PMID: 40049833](https://pubmed.ncbi.nlm.nih.gov/40049833/). *Taiwanese journal of obstetrics & gynecology*. [Case Report / Case Series]
Chen CP (2025). [PMID: 40602980](https://pubmed.ncbi.nlm.nih.gov/40602980/). *Taiwanese journal of obstetrics & gynecology*. [Case Report / Case Series]
Arene ML (2025). [PMID: 41271026](https://pubmed.ncbi.nlm.nih.gov/41271026/). *Gynecologie, obstetrique, fertilite & senologie*. [Diagnostic / Biomarker]
Chen Y (2025). [PMID: 40683916](https://pubmed.ncbi.nlm.nih.gov/40683916/). *Scientific reports*. [Epidemiology / Natural History]
Yue SSK (2025). [PMID: 39572083](https://pubmed.ncbi.nlm.nih.gov/39572083/). *Gut*. [Basic Science / Preclinical]
Huang Y (2025). [PMID: 40799956](https://pubmed.ncbi.nlm.nih.gov/40799956/). *Practical laboratory medicine*. [Case Report / Case Series]
Rizea RE (2024). [PMID: 38855489](https://pubmed.ncbi.nlm.nih.gov/38855489/). *Cureus*. [Case Report / Case Series]
Soster E (2024). [PMID: 38627791](https://pubmed.ncbi.nlm.nih.gov/38627791/). *Molecular cytogenetics*. [Clinical Trial Publication]